Education, Training and Certification
Crucial Conversations: Fostering Dialogue at all Levels of Your
Organization (2013)
VitalSmarts, Provo, Utah, USA
Structured Clinical Interview for the Diagnostic and Statistical
Manual (2012)
Centre for Addiction and Mental Health (CAMH), Toronto, ON,
Canada
Training Enhancement in Applied Cessation Counseling and Health
(2012)
University of Toronto, Faculty of Medicine, Toronto, ON, Canada
Regulatory Documentation and Research Binder (2012)
CAMH, Toronto, ON, Canada
Good Clinical Practice (2012)
Health Canada
TCPS-2: Ethical Conduct for Research Including Humans (2012)
Health Canada
Medical Devices (2012)
Health Canada
Post-Doctoral Fellowship in Biopsychology (2011)
CAMH, Toronto, ON, Canada
Ph.D. in Psychology and Neuroscience (2007)
McMaster University, Hamilton, ON, Canada
M.A. in Psychology (1998)
Wilfrid Laurier University, Waterloo, ON, Canada
Hon.B.Sc. in Psychology (1996)
University of Toronto, Toronto, ON, Canada
Awards
Post-Doctoral Fellowship (2010)
CAMH, Department of Neuroscience, Toronto, ON, Canada
Travel Award (2010)
University of Toronto, Neuroscience Program, Toronto, ON, Canada
Graduate Scholarship (1996)
Wilfrid Laurier University, Department of Psychology, Waterloo,
ON, Canada
Hon.B.Sc. Awarded with Distinction (1996)
University of Toronto, Toronto, ON, Canada
Employment
Psychology and Neuroscience Consultant and Editor (Dec 2103-Current)
Cactus Communications Inc., Trevose, PA, USA
Research Coordinator (Mar 2012-Dec 2013)
CAMH, Toronto, ON, Canada
Course Coordinator (2012-Current)
University of Toronto, Department of Psychology, Toronto,
ON, Canada
Sessional Professor, Drugs and Behaviour (2012)
Wilfrid Laurier University, Department of Psychology, Brantford,
ON, Canada
Sessional Professor, Introduction to Learning and Behaviour (2011)
Wilfrid Laurier University, Department of Psychology, Waterloo,
ON, Canada
Post-Doctoral Fellow (2007-2011)
CAMH, Department of Neuroscience, Biopsychology and Neuroimaging
Sections,
Toronto, ON, Canada
Sessional Professor, Behavioural Disorders (2006)
Ryerson University, Department of Psychology, Toronto, ON,
Canada
Sessional Professor, Abnormal Psychology - Major Disorders (2006)
McMaster University, Department of Psychology and Neuroscience,
Hamilton, ON, Canada
Sessional Professor, Fundamentals of Abnormal Psychology (2005)
McMaster University, Department of Psychology and Neuroscience,
Hamilton, ON, Canada
Teaching Assistant and Guest Lecturer, Fundamentals of Abnormal
Psychology; Abnormal Psychology - Major Disorders; Fundamentals of
Neuroscience; Neurobiology of Learning and Memory; Animal Learning and
Behaviour; Social Psychology (2000-2005)
McMaster University, Department of Psychology and Neuroscience,
Hamilton, ON, Canada
Lab Administrator and Technician (2001-2006)
McMaster University, Department of Psychology and Neuroscience,
Hamilton, ON, Canada
Tutorial Instructor, Health Statistics (2000)
McMaster University, Department of Health Sciences, Hamilton,
ON, Canada
Research Assistant (1998-2000)
University of Western Ontario, Department of Neuroscience,
London, ON, Canada
Laboratory Instructor, Biology (1998-2000)
University of Western Ontario, Department of Neuroscience,
London, ON, Canada
Laboratory Instructor, Learning and Behaviour; Psychobiology (1996-
1998)
Wilfrid Laurier University, Department of Psychology, Waterloo,
ON, Canada
Research Assistant (1996-1998)
Wilfrid Laurier University, Department of Psychology, Waterloo,
ON, Canada
Research Assistant (1995)
University of Toronto, Department of Psychology, Toronto, ON,
Canada
Professional Memberships
Canadian College of Neuropsychopharmacology (CCNP) Canadian
Neuroscience Association (CAN)
Society for Neuroscience (SfN) Schizophrenia Research Society (SRS)
Committees and Boards (1997-Current)
Board of Directors (2010-Current)
St. Leonard's Community Services, Brantford, ON, Canada
Joint Health and Safety Committee (2004-2006)
McMaster University, Dept of Psychology and Neuroscience,
Hamilton, ON, Canada
Animal Care Committee (1997-1998)
Wilfrid Laurier University, Department of Psychology, Waterloo, ON,
Canada
Clinical Practicum (1995-2013)
Clinical Units (Mar 2012- Dec 2013)
Addictions, Mood Disorders, Anxiety Disorders, Psychosis and
Schizophrenia, Geriatric Mental Health, Child Youth & Family
Services, Women's Services, Forensics, Dual Diagnosis, Eating
Disorders, Sexual/Gender Disorders, Concurrent and Complex
Mental Illness.
CAMH, Toronto, ON, Canada
First Episode Psychosis Unit (2007-2008)
CAMH, Toronto, ON, Canada
Psychiatry Division (1995)
Northwestern General Hospital, Toronto, ON, Canada
Psychophathology Out-Patient Rehabilitative Centre (1995)
Centenary Hospital, Toronto, ON, Canada
Clinical Assessment (Mar 2012 - Dec 2013)
SCID (Structured Clinical Interview for the Diagnostic &
Statistical Manual of Disorders)
Evaluation, assessment, and diagnosis of mood disorders, anxiety
disorders, substance abuse and dependence, alcohol abuse and
dependence, psychotic disorders, eating disorders, somatoform
disorders, and adjustment disorders.
Assessment Questionnaires and Personality Inventories
Evaluation and assessment of mood, alcohol dependency, nicotine
dependency, drug craving, and personality.
Pre-Clinical Research (1996-2009)
. The effects of cholinergic stimulation on rewarding brain
stimulation (rodent model, stereotaxic surgery, electrophysiology)
. The effects of dopaminergic and cholinergic modulation on numerical
and temporal cognition (rodent and pigeon models, behavioural
pharmacology)
. The effects of dopaminergic modulation on prefrontal cortex
synaptic plasticity (rodent model, stereotaxic surgery,
electrophysiology, behavioural pharmacology)
. The effects of dopaminergic stabilizers on conditioned reward and
behavioural sensitization (rodent model, behavioural pharmacology,
locomotor sensitization)
Clinical Research (Mar 2011 - Dec 2013)
transcranial Direct Current Stimulation (tDCS) and Smoking Cessation:
This project delivers the current standard treatment for smoking
cessation (cognitive behavioural therapy / CBT plus nicotine patch)
combined with the administration of tDCS to the dorsolateral
prefrontal cortex or orbitofrontal cortex. The neuronal plasticity
induced by tDCS is hypothesized to consolidate what is learned in CBT
and functionally translate into greater quit outcomes. I am
responsible for experimental design, participant recruitment,
participant informed consent, clinical assessment, administration of
tDCS, administration of clinical questionnaires and cognitive tasks,
participant follow-up, data collection and organization, adverse event
monitoring, all regulatory documentation, and statistical analysis.
(CAMH, Toronto, ON, Canada)
Project/Program Oversight/Leadership and Knowledge Translation (Mar 2012 -
Dec 2013)
Sex, Drugs, and Rock n' Roll - Development and delivery of an
undergraduate capstone course offered to Psychology Majors through the
Department of Psychology. The course includes neuroscientific and
psychosocial topics, as well as an overview of cognitive-behavioural
schemas and pharmacological approaches used to conceptualize and treat
addictions. The health, social, legal and ethical consequences of
addiction are reviewed within a biopsychosocial framework used to
develop a model that understands addiction as a developmental and
chronic disorder of consumption with broader societal implications.
(University of Toronto, Toronto, ON, Canada)
Journal Club - Presentation and discussion of addiction and mental
health related literature to research, clinical, teaching, knowledge
translation, and student populations. (CAMH, Toronto, ON, Canada)
Pregnets (Prevention of Gestational and Neonatal Exposure to Tobacco
Smoke) - Improving the health of mothers and their babies by offering
information, resources and support to pregnant and postpartum women
and their health care providers. (CAMH, Toronto, ON, Canada)
Quit360 - Development of a pilot program to build on existing smoking
cessation infrastructure within community pharmacies by providing
additional training and coaching via a multi-faceted approach that
includes ongoing training and coaching support for pharmacists. (CAMH,
Toronto, ON, Canada)
Ministry of Health and Long-Term Care Literature Review - A
comprehensive review of smoking cessation treatment and serious mental
illness and addiction (monopolar depression, bipolar disorder,
anxiety, schizophrenia, and substance abuse). (CAMH, Toronto, ON,
Canada)
transcranial Direct Current Stimulation (tDCS) - Development,
implementation, and management of a Nordocs Technologies Inc.-
sponsored and Ontario Brain Institute (OBI)-funded research project.
This includes participant recruitment, compilation of Case Report
Forms, Research Binder compilation, sponsor-funder-Health Canada
liaising, development of standard operating procedures and protocols,
training clinical and research staff, and developing project time-
lines. (CAMH, Toronto, ON, Canada)
Supervision and Management (2001-2013)
. Study manager and facilitator
. Graduate student training and supervision
. Research project staff training and supervision
Operating Plans, Budgets and Funding Initiatives (2000-2013)
. Yearly involvement in (Canadian Institute for Health Research)
(CIHR) funding project development and grant submission
. Management of research project budgets
Selected Publications in Refereed Journals (n e Coppa)
Featherstone, R.E., Burton, C.L., Coppa-Hopman, R.D., Rizos, Z.,
Sinyard, J., Kapur, S., Fletcher, P.J. (2009). Gestational treatment with
methylazoxymethanol (MAM) that disrupts hippocampal-dependent memory does
not alter behavioural response to cocaine. Pharmacology, Biochemistry, and
Behavior, 93(4): 382-90.
Coppa-Hopman, R.D., Galle, J., and Pimkine, D. (2009) D1 receptor
antagonist-induced long- term depression in the medial prefrontal cortex,
in vivo: An animal model of psychiatric hypofrontality. Journal of
Psychopharmacology, 23(6): 672-685.
Santi, A. and Coppa, R. (2001) Effects of the dopamine D2 agonist
quinpirole on time and number processing in rats. Pharmacology,
Biochemistry, and Behaviour, 68, 147-155.
Selected Conference Participation (n e Coppa)
Coppa-Hopman, R.D., Kapur, S., Nobrega, J., and Fletcher, P. (2010,
February). The Behavioural/Dopamine Stabilizers OSU6162 and ACR16 Block
Amphetamine Induced Conditioned Reinforcement. Presented at the Centre for
Addiction and Mental Health Research Day, Toronto, Canada.
Coppa-Hopman, R.D., Kapur, S., Nobrega, J., and Fletcher, P. (2010,
November). The Behavioural/Dopamine Stabilizers OSU6162 and ACR16 Block
Amphetamine Induced Locomotor Sensitization. Presented at the Society for
Neuroscience, San Diego, Conference Centre, U.S.A.
Coppa-Hopman, R.D., Kapur, S., Nobrega, J., and Fletcher, P. (2010,
June). The effects of
behavioural stabilizer pre-treatment on amphetamine-induced sensitization.
Presented at the
Harvey Stancer Research Meeting, Convention Centre, Toronto, Ontario,
Canada.
Coppa-Hopman, R.D., Kapur, S., Nobrega, J., and Fletcher, P. (2010,
May). The effects of behavioural stabilizer pre-treatment on amphetamine-
induced sensitization. Presented at the Canadian Neuroscience Meeting,
Westin Hotel, Ottawa, Ontario, Canada.
Coppa-Hopman, R.D., Kapur, S., Nobrega, J., and Fletcher, P. (2010,
March). The effects of behavioural stabilizers on hypo- and
hyperdopaminergic-induced aberrations in conditioned reward. Presented at
the CAMH Neuroscience Research Meeting, University of Toronto, Faculty
Club, Toronto, ON.
Coppa-Hopman, R.D., Kapur, S., Nobrega, J., and Fletcher, P.
(2009, November). The
effects of behavioural stabilizers on hypo- and hyperdopaminergic-induced
aberrations in conditioned reward. Presented at the Society for
Neuroscience Conference, McCormick Place, San Diego, Conference Centre,
U.S.A.
Coppa-Hopman, R.D. and Racine, R. (2007, May) D2 receptor-based
dopaminergic modulation of glutamatergic-based long-term potentiation in
the medial prefrontal cortex, in vivo: Maintenance of Behavioural
Sensitization Revisited. Presented at the Canadian Association for
Neuroscience, Chestnut Conference Centre, Toronto, Ontario, Canada.